Targeting Head and Neck Cancer Stem Cells to Overcome Resistance to Photon and Carbon Ion Radiation

Although promising new radiation therapy techniques such as hadrontherapy are currently being evaluated in the treatment of head and neck malignancies, local control of head and neck squamous cell carcinoma (HNSCC) remains low. Here, we investigated the involvement of cancer stem-like cells (CSCs) in a radioresistant HNSCC cell line (SQ20B). Stem-like cells SQ20B/SidePopulation(SP)/CD44+/ALDHhigh were more resistant to both photon and carbon ion irradiation compared with non-CSCs. This was confirmed by a BrdU labeling experiment, which suggests that CSCs were able to proliferate and to induce tumorigenicity after irradiation. SQ20B/SP/CD44+/ALDHhigh were capable of an extended G2/M arrest phase in response to photon or carbon ion irradiation compared with non-CSCs. Moreover, our data strongly suggest that resistance of CSCs may result from an imbalance between exacerbated self-renewal and proliferative capacities and the decrease in apoptotic cell death triggering. In order to modulate these processes, two targeted pharmacological strategies were tested. Firstly, UCN-01, a checkpoint kinase (Chk1) inhibitor, induced the relapse of G2/M arrest and radiosensitization of SQ20B-CSCs. Secondly, all-trans retinoic acid (ATRA) resulted in an inhibition of ALDH activity, and induction of the differentiation and radiosensitization of SQ20B/SP/CD44+/ALDHhigh cells. The combination of ATRA and UCN-01 treatments with irradiation drastically decreased the surviving fraction at 2Gy of SQ20B-CSCs from 0.85 to 0.38 after photon irradiation, and from 0.45 to 0.21 in response to carbon ions. Taken together, our results suggest that the combination of UCN-01 and ATRA represent a promising pharmacological-targeted strategy that significantly sensitizes CSCs to photon or carbon ion radiation.

[1]  M. Herlyn,et al.  Stem-like cells and therapy resistance in squamous cell carcinomas. , 2012, Advances in pharmacology.

[2]  Tania L. Slatter,et al.  Telomere Profiling: Toward Glioblastoma Personalized Medicine , 2012, Molecular Neurobiology.

[3]  Dominique Ardail,et al.  Glutathione Depletion and Carbon Ion Radiation Potentiate Clustered DNA Lesions, Cell Death and Prevent Chromosomal Changes in Cancer Cells Progeny , 2012, PloS one.

[4]  H. Tsujii,et al.  Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. , 2004, International journal of radiation oncology, biology, physics.

[5]  E. Cohen,et al.  Current Treatment Options for Metastatic Head and Neck Cancer , 2012, Current Treatment Options in Oncology.

[6]  H. Pyo,et al.  Celecoxib enhances the radiosensitizing effect of 7-hydroxystaurosporine (UCN-01) in human lung cancer cell lines. , 2012, International journal of radiation oncology, biology, physics.

[7]  S. Trapasso,et al.  Role of CD44 as a marker of cancer stem cells in head and neck cancer , 2012, Biologics : targets & therapy.

[8]  F. Bertucci,et al.  Retinoid signaling regulates breast cancer stem cell differentiation , 2009, Cell cycle.

[9]  M. Wicha,et al.  Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. , 2010, Cancer research.

[10]  S. Trapasso,et al.  Cancer stem cells in head and neck cancer , 2012, OncoTargets and therapy.

[11]  I. Weissman,et al.  Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.

[12]  M. Krause,et al.  Exploring the role of cancer stem cells in radioresistance , 2008, Nature Reviews Cancer.

[13]  Dominique Ardail,et al.  Transient Alteration of Cellular Redox Buffering before Irradiation Triggers Apoptosis in Head and Neck Carcinoma Stem and Non-Stem Cells , 2011, PloS one.

[14]  H. Tsujii,et al.  High linear energy transfer carbon radiation effectively kills cultured glioma cells with either mutant or wild-type p53. , 2001, International journal of radiation oncology, biology, physics.

[15]  E. Choi,et al.  All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/β-catenin pathway. , 2012, European journal of cancer.

[16]  Guang-Yuh Chiou,et al.  Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1. , 2010, Oral oncology.

[17]  Ping Wu,et al.  Effects of All-trans Retinoic Acid (ATRA) on Human Myeloma Cells , 2003, Leukemia & lymphoma.

[18]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[19]  O. Yokosuka,et al.  Different effects of carbon ion beams and X-rays on clonogenic survival and DNA repair in human pancreatic cancer stem-like cells. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  Irving L. Weissman,et al.  Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.

[21]  D. Hwang,et al.  CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma. , 2012, Cancer letters.

[22]  Alysha K Croker,et al.  Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells , 2012, Breast Cancer Research and Treatment.

[23]  J. Debus,et al.  In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells , 2012, Radiation Oncology.

[24]  Dominique Ardail,et al.  Targeting a cornerstone of radiation resistance: cancer stem cell. , 2012, Cancer letters.

[25]  R. Caltabiano,et al.  Nuclear BMI-1 expression in laryngeal carcinoma correlates with lymph node pathological status , 2012, World Journal of Surgical Oncology.

[26]  K. Trott.  Cell repopulation and overall treatment time. , 1990, International journal of radiation oncology, biology, physics.

[27]  A. Jimeno,et al.  Phase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumors , 2008, Cancer Chemotherapy and Pharmacology.

[28]  Yi-Wei Chen,et al.  Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. , 2009, Biochemical and biophysical research communications.

[29]  Deborah Citrin,et al.  In vitro and In vivo Radiosensitization with AZD6244 (ARRY-142886), an Inhibitor of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase 1/2 Kinase , 2009, Clinical Cancer Research.

[30]  R. Okayasu,et al.  Effects of carbon ion beam on putative colon cancer stem cells and its comparison with X-rays. , 2011, Cancer research.

[31]  L. Playle,et al.  Abrogation of the radiation-induced G2 checkpoint by the staurosporine derivative UCN-01 is associated with radiosensitisation in a subset of colorectal tumour cell lines , 2002, British Journal of Cancer.

[32]  M. Beuve,et al.  Different mechanisms of cell death in radiosensitive and radioresistant p53 mutated head and neck squamous cell carcinoma cell lines exposed to carbon ions and x-rays. , 2009, International journal of radiation oncology, biology, physics.

[33]  F. Recchia,et al.  Ifosfamide, cisplatin, and 13‐Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck , 2001, Cancer.

[34]  J. Kyula,et al.  Targeted radiosensitization by the Chk1 inhibitor SAR-020106. , 2013, International journal of radiation oncology, biology, physics.

[35]  M. Wicha,et al.  Single‐marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase , 2010, Head & neck.

[36]  M. Beuve,et al.  Radiobiologic parameters and local effect model predictions for head-and-neck squamous cell carcinomas exposed to high linear energy transfer ions. , 2008, International journal of radiation oncology, biology, physics.

[37]  Mengzhong Liu,et al.  Chk1 inhibitor Gö6976 enhances the sensitivity of nasopharyngeal carcinoma cells to radiotherapy and chemotherapy in vitro and in vivo. , 2010, Cancer letters.

[38]  H. Tsujii,et al.  Carbon ion radiation therapy improves the prognosis of unresectable adult bone and soft-tissue sarcoma of the head and neck. , 2012, International journal of radiation oncology, biology, physics.

[39]  K. Black,et al.  Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma , 2006, Molecular Cancer.

[40]  M. Lippman,et al.  Breast Cancer Research and Treatment , 2004, Breast Cancer Research and Treatment.

[41]  Tadashi Kamada,et al.  Results of carbon ion radiotherapy for head and neck cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[42]  G. Steel,et al.  Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. , 1979, International journal of radiation oncology, biology, physics.

[43]  J. Mi.  Current treatment strategy of acute promyelocytic leukemia , 2011, Frontiers of medicine.

[44]  Z. Karabekian,et al.  Stem Cell Rev and Rep , 2010 .

[45]  M. Ljungman.  The DNA damage response—Repair or despair? , 2010, Environmental and molecular mutagenesis.

[46]  A. Giatromanolaki,et al.  Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head–neck cancer , 2012, British Journal of Cancer.